Shanghai Chemspec Corporation Class A

Shanghai Chemspec Corporation Class A

SSSE:688602
7.40
CNY
+0.90
(+13.85%)
-0.18EPS
4.09BMarket Cap
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.4
2.55
2.75
1.9
1.74
2.62
2.95
2.17
1.36
1.44
1.24
Basic EPS, GAAP
0.47
0.53
1.25
0.39
0.25
0.35
0.43
0.25
-0.1
-0.12
-0.18
Free Cash Flow per Basic Share
0.29
-0.11
0.13
-0.23
-0.36
-0.2
0.03
0.18
-0.2
0.02
- -
Dividend per Share
0.01
0.01
2.13
0.23
0.03
0.03
0.02
0.02
0.08
0.01
0.01
Book Value per Share
4.06
4.58
3.54
2.84
3.1
3.9
4.41
5.33
5.34
5.23
5.18
Tangible Book Value per Share
3.45
3.9
3.37
2.68
2.95
3.77
4.29
5.2
5.2
5.1
5.05
Basic Weighted Avg Shares
250
250
258
362
361
383
420
451
495
535
547
Sales/Revenue/Turnover
599
637
708
687
629
1,005
1,238
980
675
770
678
Operating Margin (%)
24.7
25.3
20.42
23.43
18.52
18.91
14.86
10.35
-14
-4.51
-12.06
Depreciation Expense
66
71
76
55
85
103
129
136
165
171
- -
Net Income, GAAP
117
132
323
141
90
134
181
113
-50
-64
-101
Effective Tax Rate (%)
14.33
12.84
14.07
13.62
10.7
5.95
8.88
8.49
- -
- -
- -
Profit Margin (%)
19.46
20.68
45.54
20.57
14.35
13.34
14.58
11.5
-7.34
-8.34
-14.85
Working Capital
691
460
422
299
103
424
597
1,541
1,434
1,490
1,381
LT Debt
- -
- -
20
129
144
93
57
92
83
101
16
Total Equity
1,125
1,251
914
1,028
1,123
1,630
1,846
2,784
2,784
2,727
2,700
Return on Invested Capital (%)
- -
11.15
26.63
12.24
7.68
8.44
9.36
4.64
- -
- -
- -
Return on Capital (%)
- -
9.89
26.89
12.32
7.25
8.42
9.37
4.7
- -
- -
- -
Return on Common Equity (%)
- -
12.18
31.36
14.61
8.43
9.8
10.46
4.9
-1.79
-2.34
-3.66

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
43
72
82
LT Borrowings
80
40
- -
LT Finance Leases
22
18
16
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
519
519
519
Market Capitalization
4,508
3,906
4,093

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,811
1,739
1,719
Cash, Cash Equivalents & STI
1,196
1,164
1,087
Accounts Receivable, Net
152
144
146
Inventories
361
367
393
Total Current Liabilities
320
288
338
Payables & Accruals
- -
- -
- -
ST Debt
43
72
82
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
21.42%
-2.07%
Free Cash Flow
- -
4.39%
-112.16%
Net Income, GAAP
- -
-13.74%
29.62%
Sales/Revenue/Turnover
- -
8.99%
14.04%
Total Cash Common Dividend
- -
55.26%
-87.75%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
169
173
183
151
675
2025
243
193
- -
173
770
2026
150
161
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
-0.02
-0.05
-0.06
-0.1
2025
0.06
- -
- -
-0.12
-0.12
2026
-0.02
-0.05
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.07
- -
- -
0.08
2025
- -
- -
- -
- -
0.01
2026
- -
- -
- -
- -
- -

Company Description

CEO
Yun Long Yuan
Full Time Employees
992
Sector
Process industries
Industry
Chemicals: major diversified
Address
Shanghai China
IPO Date
Jul 20, 2023
Business
Shanghai Chemspec Corporation is a China-based fine chemicals and advanced materials company engaged in the research, development, manufacture, and commercialization of specialty fluorochemicals, new energy battery materials, electronic chemicals, and life science intermediates. Founded in 1996 and headquartered in Shanghai, China, the company operates across several core business segments, offering: display and electronic chemicals, including fluorinated liquid crystal monomers and intermediates, organic light-emitting diode (OLED) materials, photoresist raw materials, and high-purity semiconductor process chemicals; new energy materials, comprising lithium bis(fluorosulfonyl)imide (LiFSI) electrolyte salts, specialized electrolyte additives, and fluorinated solvent compounds for electric vehicle batteries and energy storage systems; pharmaceutical intermediates and custom development and manufacturing organization (CDMO) services, encompassing advanced fluorinated active pharmaceutical ingredient (API) building blocks, heterocyclic intermediates, and custom synthesis for global innovator pharmaceutical companies; and agrochemical intermediates and specialty fine chemicals, including fluorinated crop protection intermediates, fluorination reagents, and customized organofluorine compounds. The company serves multinational and domestic clients across the semiconductor, flat panel display, renewable energy, automotive, pharmaceutical, and crop protection industries, maintaining research and development centers and advanced manufacturing complexes in Shanghai, Zhejiang, and Gansu provinces, with commercial reach extending across China, North America, Europe, Japan, and other international markets. In recent developments, Shanghai Chemspec Corporation completed its initial public offering and listed its Class A shares on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange under the ticker 688602. Over the past two years, the company has executed significant operational expansions to strengthen its position in the new energy and electronic materials supply chains, notably ramping up industrial-scale production capacity for high-purity LiFSI battery electrolyte salts to address accelerating demand from next-generation lithium-ion battery and solid-state battery manufacturers. The company has also expanded its manufacturing infrastructure through phased investments at its Lanzhou and Quzhou production bases, scaling up capacity for specialty fluorinated intermediates, ultra-pure electronic chemicals, and pharmaceutical CDMO pipelines. Furthermore, Chemspec has deepened strategic supply and development partnerships with leading international life science enterprises and domestic battery material producers, while increasing research and development allocation toward advanced fluorinated polymers, semiconductor-grade cleaning agents, and high-performance dielectric materials.